Lifshitz & Miller Law Firm Announces Investigation of Auspex Pharmaceuticals, Inc., BioScrip, Inc., Catamaran Corporation, Cellular Dynamics International, Inc., First Security Group, Inc., Hyperion Therapeutics, Inc., and Norcraft Companies, Inc.

NEW YORK, April 3, 2015 /PRNewswire/ --

Auspex Pharmaceuticals, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Auspex Pharmaceuticals, Inc. ("ASPX") to Teva Pharmaceutical Industries Ltd. in a cash transaction valued at approximately $3.5 billion or $101.00 per share.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

BioScrip, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board of BioScrip, Inc. ("BIOS").  On March 31, 2015, a federal judge denied, in part, a motion to dismiss a complaint alleging that BIOS had made misleading statements pertaining to (i) the distribution of the Novartis Pharmaceutical Corporation's product Exjade® by BIOS' May 2012 divested legacy specialty pharmacy division; and (ii) BIOS' PBM Services segment.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Catamaran Corporation

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Catamaran Corporation ("CTRX") to OptumRx in a transaction valued at $61.50 per share.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Cellular Dynamics International, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Cellular Dynamics International, Inc. ("ICEL") to FUJIFILM Holdings Corporation in a transaction valued at $307 million or $16.50 per share.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

First Security Group, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of First Security Group, Inc. ("FSGI") to Atlantic Capital Bancshares, Inc. in a transaction valued at $160 million or $2.35 per share.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Hyperion Therapeutics, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Hyperion Therapeutics, Inc. to Horizon Pharma plc in a transaction valued at $1.1 billion or $46.00 per share.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Norcraft Companies, Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Norcraft Companies, Inc. ("NCFT") to Fortune Brands Home & Security, Inc. in a transaction valued at $600 million or $25.50 per share.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

ATTORNEY ADVERTISING. © 2015 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com